Yellow Fever Clinical Trial
Official title:
Yellow Fever Human Infection Model With YF-17D
No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving.
No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01436396 -
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
|
Phase 3 | |
| Recruiting |
NCT05568953 -
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
|
Phase 2 | |
| Recruiting |
NCT05447377 -
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants
|
Phase 3 | |
| Active, not recruiting |
NCT05011123 -
Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia
|
Phase 2 | |
| Completed |
NCT04267809 -
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection
|
Phase 2 | |
| Completed |
NCT01943305 -
The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans
|
Phase 2 | |
| Completed |
NCT02991495 -
Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)
|
Phase 4 | |
| Not yet recruiting |
NCT03725618 -
Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old
|
Phase 4 | |
| Completed |
NCT01466387 -
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
|
Phase 3 | |
| Completed |
NCT04059471 -
Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine
|
Phase 4 | |
| Completed |
NCT02572518 -
Immunity After Two Doses of Yellow Fever Vaccine
|
N/A | |
| Recruiting |
NCT00694655 -
Human Immune Responses to Yellow Fever Vaccination
|
Phase 4 | |
| Not yet recruiting |
NCT05332197 -
Booster Vaccine for Yellow Fever
|
Phase 3 | |
| Recruiting |
NCT05421611 -
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
|
Phase 3 | |
| Completed |
NCT03116802 -
Yellow Fever Vaccine on Statin/ Non Statin Subjects
|
Phase 2 | |
| Completed |
NCT02743455 -
A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01426243 -
The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.
|
Phase 3 | |
| Completed |
NCT00982137 -
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)
|
Phase 2 | |
| Active, not recruiting |
NCT04269265 -
The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination
|
Phase 1/Phase 2 | |
| Completed |
NCT03870061 -
Evaluation of an Infant Immunization Encouragement Program in Nigeria
|
N/A |